Navigation Links
WellGen, Inc. Names Robert M. Hellauer as Chief Financial Officer

NORTH BRUNSWICK, N.J., Feb. 12 /PRNewswire/ -- WellGen, Inc., a biotechnology company using nutrigenomics to discover and develop food ingredients for wellness products, today announced the appointment of Robert M. Hellauer as Chief Financial Officer.

Mr. Hellauer, 56, comes to WellGen with over thirty years of broad financial leadership in the pharmaceutical, consumer and telecommunications industries. Prior to joining WellGen, he spent six years in private equity and venture-backed environments. Mr. Hellauer's earlier experience includes senior positions at Lucent Technologies / AT&T, General Signal Corporation, and Johnson & Johnson.

Dr. Kathleen Mullinix, Chief Executive Officer of WellGen, said, "Bob joins WellGen at a strategically important period, as we emerge from our origins as a research boutique and gain traction as a commercial entity. The role of Chief Financial Officer will be critical to ensuring a successful, sustainable business as we roll out our first functional food ingredient to the marketplace and significantly expand the number of ingredients in our pipeline."

Mr. Hellauer graduated from the University of Pennsylvania, where he received a Bachelor of Science degree and a Master of Business Administration degree from The Wharton School.

About WellGen

WellGen, Inc., based in North Brunswick, NJ, is a biotechnology company that is discovering and developing products for the food, therapeutics, and dietary supplement markets, with a strategic focus on functional foods. WellGen's proprietary technology platform is a method of screening the effects of food and related substances on the expression of genes associated with human health conditions. The company has developed proprietary substances that help maintain health and reduce risk and severity for a variety of diseases. Please visit our website at for more information.

SOURCE WellGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. WellGen, Inc. Names Nancy E. Rawson, Ph.D., Chief Scientific Officer
2. Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer
3. Profectus BioSciences Inc. Names Shawn Patrick OBrien CEO
4. VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
5. CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer
6. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
7. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
8. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
9. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
10. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):